|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||23.77 - 24.67|
|52-week range||13.89 - 44.34|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||2.73|
|Earnings date||20 Feb 2024 - 26 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.
SAN DIEGO, December 06, 2023--Tandem Diabetes Care today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 CGM integration in the United States.
Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ), might not be a large cap stock, but it received a lot of attention from a...